1.FDA approves first precision medicine for the treatment of cancers with certain genetic defects, including prostate cancer:
2. Lutetium 177 PSMA radionuclide therapy for men with prostate cancer: a review of the current literature and discussion of practical aspects of therapy:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355374/
3, Compare Prostate Cancer Treatments for Low Risk Category:
http://www.pctrf.org/low-risk-results/